Clinical Trial Update: Multicenter Study in Postmenopausal Women With Osteoporosis, ALVOBOND [Phase 3]

View source ↗

Summary

Phase 3 multicenter trial of ALVOBOND in postmenopausal osteoporosis has completed. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• ALVOBOND

Snippet

Sponsor: Alvotech Swiss AG | Conditions: Osteoporosis, Postmenopausal | Phase 3 | Status: COMPLETED | Results posted: 2025-05-29